High-tech glasses developed at Washington University School of Medicine in St. Louis may help surgeons visualize cancer cells, which glow blue when viewed through the eyewear.
The wearable technology, so new it’s yet unnamed, was used during surgery for the first time today at Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
Cancer cells are notoriously difficult to see, even under high-powered magnification. The glasses are designed to make it easier for surgeons to distinguish cancer cells from healthy cells, helping to ensure that no stray tumor cells are left behind during surgery.
“We’re in the early stages of this technology, and more development and testing will be done, but we’re certainly encouraged by the potential benefits to patients,” said breast surgeon Julie Margenthaler, MD, an associate professor of surgery at Washington University, who performed today’s operation. “Imagine what it would mean if these glasses eliminated the need for follow-up surgery and the associated pain, inconvenience and anxiety.”
Current standard of care requires surgeons to remove the tumor and some neighboring tissue that may or may not include cancer cells. The samples are sent to a pathology lab and viewed under a microscope. If cancer cells are found in neighboring tissue, a second surgery often is recommended to remove additional tissue that also is checked for the presence of cancer.
The glasses could reduce the need for additional surgical procedures and subsequent stress on patients, as well as time and expense.
Margenthaler said about 20 to 25 percent of breast cancer patients who have lumps removed require a second surgery because current technology doesn’t adequately show the extent of the disease during the first operation.
“Our hope is that this new technology will reduce or ideally eliminate the need for a second surgery,” she said.
The technology, developed by a team led by Samuel Achilefu, PhD, professor of radiology and biomedical engineering at Washington University, incorporates custom video technology, a head-mounted display and a targeted molecular agent that attaches to cancer cells, making them glow when viewed with the glasses.
The Latest on: Seeing cancer
via Google News
The Latest on: Seeing cancer
- Racism turned their neighborhood into 'Cancer Alley.’ Now they’re dying from COVID-19.on October 12, 2020 at 4:45 pm
Americans living in "Cancer Alley" suffer from high rates of cancer. In this six-part series, USA TODAY investigates how racism fuels COVID-19 deaths.
- NBC's Kristen Dahlgren shares the unusual breast cancer symptom she nearly missedon October 12, 2020 at 11:25 am
A research study from the U.K. had found that around 1 in 6 women diagnosed with breast cancer went to the doctor with a symptom other than a lump. While lumps are still the most commonly reported ...
- Balstilimab, Zalifrelimab Active in Advanced Cervical Canceron October 12, 2020 at 11:12 am
Checkpoint blockade with the PD-1 inhibitor balstilimab, alone or in combination with the anti-CTLA-4 drug zalifrelimab, showed activity in women with recurrent or metastatic cervical cancer, ...
- 'We're in danger of replacing one health crisis with another': 3 million Britons missing out on cancer screening since Marchon October 12, 2020 at 9:29 am
Around 3 million people in the UK are thought to have missed out on cancer screening since the end of March, a report has revealed. The coronavirus outbreak has triggered restrictions that leave many ...
- 11-year-old with rare cancer blogs to show good and bad sides of diseaseon October 12, 2020 at 8:28 am
While facing a rare cancer for the second time at 11 could be scary for most, Nevaeh Williams is sharing her experience on social media to inspire others.
- Pfizer's (PFE) Ibrance Fails in Early Breast Cancer Studyon October 12, 2020 at 8:14 am
PFE announced that a phase III study evaluating its blockbuster drug, Ibrance, in patients with high-risk early breast cancer failed to meet the primary endpoint. The PENELOPE-B study (n= 1,250) ...
- GUEST COMMENT: Disparities create inequity in care for breast cancer patientson October 12, 2020 at 7:28 am
Some people have a much lower chance for a successful treatment outcome because of the barriers they face. This is something we should talk more about. How can we as a community do our part to improve ...
- My 3-year-old was handling the pandemic well. Then his mom was diagnosed with cancer.on October 12, 2020 at 6:05 am
The thought of my little boy losing his mama was unbearable. I don’t know if he noticed my puffy eyes. But he became quieter, more thoughtful.
- Lung cancer referrals down 50% 'because patients believe their cough is Covid-19 and self-isolate instead of seeing a specialist' - as figures show 3million people missed out ...on October 12, 2020 at 5:44 am
About 16,000 fewer patients than doctors would expect have been urgently referred for lung cancer tests in England since March, according to Cancer Research UK.
- Scientists develop new 'precision medicine' approach to treating damaged DNA in pancreatic canceron October 12, 2020 at 4:56 am
Scientists have developed a new "precision medicine" approach to treating the damaged DNA in the cancer cells of Pancreatic Cancer patients.
via Bing News